PRUNE1 and neoplasm: To evaluate the importance and potential of h-Prune as an early tumour marker in lung cancer, a total of 14 lung cancer patients (stage I-II) (Supplementary Table S3) and 14 healthy controls were enrolled in this study and the serum levels of h-Prune were assessed using ELISA assays.